Concern Rises over Mobile Computer-Spread Infections


Author: Neil Versel
Physicians are embracing computers and other health-IT at the point of care more than ever before, but with increased availability of technology comes greater scrutiny and a heightened awareness of potential problems, a new report suggests.

Indeed, 65 percent of tech-savvy physicians surveyed this year are concerned that mobile computing devices could raise the risk of infection, according to a study on point-of-care computing from Spyglass Consulting Group (Menlo Park, Calif.). That is up from 25 percent who mentioned this potential hazard in a 2005 Spyglass report on mobile healthcare technology.

This, according to Spyglass, should necessitate policies for use of handheld devices in the presence of patients. “Existing computing devices should leverage temporary infection barriers to prevent cross contamination, including keyboard condoms and Ziploc bags. New computing devices should be water-resistant and made of anti-microbial plastics,” the report says.

The problem of mobile devices spreading infections may be less acute than perceived, however, since fixed computers, many with multiple high-resolution displays, are becoming more prevalent at the point of care. “Now we see that there’s been a migration away from mobile,” says Gregg Malkary, Spyglass Consulting’s managing director.

In 2005, Malkary thought that personal digital assistants (PDAs) and smartphones would catch on for such tasks as charge capture, e-prescribing, bedside charting, and even viewing of radiological images. “There was a lot of hype a few years ago,” Malkary says. “But [for physicians today] it’s purely a communications device.”

Malkary says that hospital networks are “saturated,” with traffic from wireless data, voice, and now radio-frequency identification systems, so the reliability and speed of untethered links may suffer. “There’s nothing like a wired connection,” he notes.

And despite improvements in wireless speed and a reduction of “dead spots” within facilities, the fact remains that the screen on most handhelds remains too small for regular clinical tasks. “It’s applicable when a larger form factor isn’t available,” Malkary says.

At least one of the physicians surveyed argued that it could be a useful tool for intensivists, where a few minutes could mean the difference between life and death for the patient if the doctor happens to be off-site at the time. “I thought that was a very compelling story, but it’s an isolated case,” Malkary says.

“That being said, the tablet PC does seem to have a home in the ambulatory environment. It’s kind of a dead-cat bounce in hospitals, though,” Malkary explains, because physicians tend not to like toting the machines around for an entire shift and because few healthcare applications have the digital “smart forms” that really differentiate the tablet from desktop and laptop computers.

He reports many tablets sitting unused on hospital shelves. “It really doesn’t connect well with workflow,” Malkary says.

Tablets may be more useful in an ambulatory setting because doctors can set the computers down more frequently without fear they will be stolen, but the machines cost more than other PCs, and physicians in private practice usually are dipping into their own pockets for hardware.

Malkary also says that computers are changing the dynamic of a physician-patient encounter. One clinical administrator at a Midwestern academic medical center says, “Patients are not used to seeing physicians use computers during an exam or treatment. Many older patients with chronic diseases or ailments would find this behavior rude and socially unacceptable.”

Spyglass interviewed 100 physicians, 96 of whom were male, and all of whom described themselves as technically competent, so the results likely are not fully representative of the nation’s physician population. The survey pool, however, is split between hospital-based and office-based doctors, and covers 21 specialties.

Want to read more expert articles like this? Click here to subscribe to Digital HealthCare & Productivity.

 

 

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

thomson reuters image
Biomarkers: An Indispensible Addition to the Drug Development Toolkit
Examining the Potential of Biomarkers
Sponsored by Thomson Reuters

Biomarkers are becoming an essential part of clinical development. In this white paper, Thomson Reuters provides insight from experts in industry and academia, and explores the role of biomarkers as evaluative tools in improving clinical research and the challenges this presents.

Discover the potential of biomarkers to:

  • Improve decision making
  • Accelerate drug development
  • Reduce development costs


BlueArc_Scientific Data
Scientific Data Lifecycle Management: Preparing for Storage in an Uncertain Future
Sponsored by BlueArc

Managing vast and overwhelming streams of gene sequencing data today requires ultra-high performance systems and processes. With continued rapid advancement and improvements in gene sequencing, expect tomorrow’s instruments to output quantities of genomic information that will dwarf current levels. Help your organization maintain data control and prepare for the future of sequencing through this informative paper that discusses:

  • The information technology challenges of gene sequencing
  • “Intelligent” methods for data management and customization
  • System survival tips... Deciding what data to keep or delete
  • New tools to keep scientists ahead of impending data torrents


SAS Managed image
Managed Innovation, Assured Compliance
Developing, executing and managing the transformation, analysis and submission of clinical research data with SAS® Drug Development
Sponsored by SAS
Get better products to market faster. Download this white paper to discover the top ten challenges facing life science executives and how to overcome them. See how SAS Drug Development transforms clinical data into true innovation.


Life Science Webcasts & Podcasts

Presented by Trade Commission of Spain

Spain Biotech: An Engine for Economic Change 

TCS podcastDiscover how Spain is focusing on biotechnology to be an engine for economic change through gradual internationalization, development and technology transfer.

Regional governments are actively investing in public and private biology research and promoting the creation of knowledge-based companies. Spain’s human capital combined with aggressive investment in biotech research and infrastructure has led to the creation of bio-clusters.

Today, there are nearly 700 Spanish companies engaged in biotechnology, with almost 50 percent growth in funding devoted to research. In fact, spending on internal R & D in biotechnology has grown 46 percent and is close to 300 million Euros.

Access the podcast 

 



More Podcasts

Job Openings

saic_logo

MANAGER, SCIENTIFIC COMPUTING & PROGRAMMING
(Bioinformatics Manager)
SAIC-Frederick, Inc has an exciting opportunity for a Manager, Scientific Computing & Programming - Core Genoytyping Facility in Gaithersburg, Maryland.  In this role, you will lead the Bioinformatics & Analysis Group.
Master’s or equivalent required.  PhD preferred. Six years experience in development of scientific programs in high-performance computing environment including five years supporting scientific research in computational chemistry, biology, or genetics, & two years supervisory experience.  View complete job posting & apply: www.saic-frederick.com. Position #146945.

For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.